剖宮產(chǎn)術(shù)圍手術(shù)期用藥的臨床對(duì)策.doc

剖宮產(chǎn)術(shù)圍手術(shù)期用藥的臨床對(duì)策.doc

ID:51923335

大?。?9.50 KB

頁(yè)數(shù):15頁(yè)

時(shí)間:2020-03-19

剖宮產(chǎn)術(shù)圍手術(shù)期用藥的臨床對(duì)策.doc_第1頁(yè)
剖宮產(chǎn)術(shù)圍手術(shù)期用藥的臨床對(duì)策.doc_第2頁(yè)
剖宮產(chǎn)術(shù)圍手術(shù)期用藥的臨床對(duì)策.doc_第3頁(yè)
剖宮產(chǎn)術(shù)圍手術(shù)期用藥的臨床對(duì)策.doc_第4頁(yè)
剖宮產(chǎn)術(shù)圍手術(shù)期用藥的臨床對(duì)策.doc_第5頁(yè)
資源描述:

《剖宮產(chǎn)術(shù)圍手術(shù)期用藥的臨床對(duì)策.doc》由會(huì)員上傳分享,免費(fèi)在線閱讀,更多相關(guān)內(nèi)容在工程資料-天天文庫(kù)

1、【摘要】目的探討剖宮產(chǎn)術(shù)圍手術(shù)期用藥的臨床對(duì)策。方法80例行剖宮產(chǎn)術(shù)產(chǎn)婦,隨機(jī)分成觀察組和對(duì)照組,各40例。觀察組產(chǎn)婦采用圍手術(shù)期抗感染用藥治療,對(duì)照組產(chǎn)婦采用圍手術(shù)期常規(guī)用藥治療,對(duì)比不同用藥后的治療效果。結(jié)果觀察組產(chǎn)婦術(shù)后退熱時(shí)間為(1.45±1.07)d,術(shù)后最高體溫為(37.80±0.20)°C,術(shù)后腹部切口感染率為2.5%(1/40),產(chǎn)褥病發(fā)生率為2.5%(1/40);對(duì)照組產(chǎn)婦術(shù)后退熱時(shí)間為(2.68±1.8)d,術(shù)后最高體溫為(38.31±0.28)°C,術(shù)后腹部切口感染率為15.0%(6/40),產(chǎn)褥病發(fā)生率為17.5%(7/40);兩組產(chǎn)婦術(shù)后退熱時(shí)間、最高體溫及腹部

2、切口感染率、產(chǎn)褥病發(fā)生率比較,差異均有統(tǒng)計(jì)學(xué)意義(Pv0.05)o結(jié)論剖宮產(chǎn)術(shù)產(chǎn)婦在圍手術(shù)期給予抗感染用藥治療可明顯縮短預(yù)防性使用抗菌藥的使用時(shí)間,降低切口感染率及產(chǎn)褥病發(fā)生率?!娟P(guān)鍵詞】剖宮產(chǎn);圍手術(shù)期;用藥;臨床對(duì)策DOI:10.14163/j.cnki.11-5547/r.2O16.33.069ClinicalcountermeasuresinperioperativemedicationofcesareansectionWULi-heng.DepartmentofObstetricsandGynecology,LiaoningYixianCountyMaternityandChi

3、ldCareHospital,Jinzhou121100,China【Abstract]ObjectiveToinvestigateclinicalcountermeasuresinperioperativemedicationofcesareansection.MethodsAtotalof80puerperareceivingcesareansectionwererandomlydividedintoobservationgroupandcontrolgroup,with40casesineachgroup.Theobservationgroupreceivedperioperati

4、veanti-inflammationmedicationtreatment,andthecontrolgroupreceivedperioperativeconventionalmedicationtreatment.Curativeeffectsafterdifferenttreatmentwerecompared.ResultsTheobservationgrouphadpostoperativefeverclearancetimeas(1.45±1.07)d,postoperativemaximalbodytemperatureas(37.80±0.20)°C,postopera

5、tiveinfectionrateofabdominalincisionas2.5%(1/40),andincideneeofpuerperalismas2.5%(1/40).Thecontrolgrouphadpostoperativefeverclearaneetimeas(2.68±1.8)d,postoperativemaximalbodytemperatureas(38.31±0.28)°C,postoperativeinfectionrateofabdominalincisionas15.0%(6/40),andincidenceofpuerperalismas17.5%(7

6、/40).Thedifferencesofpostoperativefeverclearancetime,maximalbodytemperature,infectionrateofabdominalincisionandincidenceofpuerperalismallhadstatisticalsignificancebetweenthetwogroups(P<0.05).ConclusionImplementofperioperativeanti-inflammationmedicationtreatmentforpuerperareceivingcesareansectionc

7、anremarkablyshortenadministrationtimeofpreventiveantibacterialandreduceinfectionrateofincisionandpuerperalism.【Keywords】Cesareansection;Perioperative;Medication;Clinicalcountermeasures剖宮產(chǎn)術(shù)是有效防止由于陰道生產(chǎn)過(guò)程中由部分原因可能造成母嬰健康和性命

當(dāng)前文檔最多預(yù)覽五頁(yè),下載文檔查看全文

此文檔下載收益歸作者所有

當(dāng)前文檔最多預(yù)覽五頁(yè),下載文檔查看全文
溫馨提示:
1. 部分包含數(shù)學(xué)公式或PPT動(dòng)畫(huà)的文件,查看預(yù)覽時(shí)可能會(huì)顯示錯(cuò)亂或異常,文件下載后無(wú)此問(wèn)題,請(qǐng)放心下載。
2. 本文檔由用戶上傳,版權(quán)歸屬用戶,天天文庫(kù)負(fù)責(zé)整理代發(fā)布。如果您對(duì)本文檔版權(quán)有爭(zhēng)議請(qǐng)及時(shí)聯(lián)系客服。
3. 下載前請(qǐng)仔細(xì)閱讀文檔內(nèi)容,確認(rèn)文檔內(nèi)容符合您的需求后進(jìn)行下載,若出現(xiàn)內(nèi)容與標(biāo)題不符可向本站投訴處理。
4. 下載文檔時(shí)可能由于網(wǎng)絡(luò)波動(dòng)等原因無(wú)法下載或下載錯(cuò)誤,付費(fèi)完成后未能成功下載的用戶請(qǐng)聯(lián)系客服處理。